An In-Depth Look at Bio-Path Holdings Inc’s (BPTH) Stock Performance

29m ago, source: newsheater

Based on Bio-Path Holdings Inc (BPTH), the company’s capital structure generated 0.2 points at debt to capital in total, while cash flow to debt ratio is standing at -102.08. The debt to equity ratio ...

Why Bio-Path Stock Is Soaring

on MSN ago, source:

Bio-Path Holdings, Inc. (NASDAQ:BPTH) shares are trading higher Thursday after the company announced the completion of its ...

Bio-Path Holdings, Inc. Announces Closing of $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

3d ago, source:

The gross proceeds to Bio-Path from the offering were approximately $1.2 million, before deducting the placement agent’s fees and other offering expenses payable by Bio-Path. Bio-Path currently ...

Bio-Path (BPTH) Rises on Upbeat Updates From Blood Cancer Study

3d ago, source:

Bio-Path (BPTH) gains 30% on encouraging developmental updates from the early-stage study of its investigational candidate, ...

Crude Oil Edges Lower; Bio-Path Holdings Shares Spike Higher

on MSN ago, source:

U.S. stocks traded higher midway through trading, with the S&P 500 gaining around 0.5% on Thursday. The Dow traded up 0.64% ...

Why Vaxxinity Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session

on MSN ago, source:

Complete Solaria, Inc. CSLR shares gained 17.4% to $0.5281 amid recent volatility in the stock. Chairman T.J. Rodgers said he ...

SBFM, BPTH and INDO among pre-market losers

on MSN ago, source:

Losers: Hepion Pharmaceuticals (HEPA) -38% initiates wind-down activities in Phase 2b ‘ASCEND-NASH’ trial. Top Wealth Group Holding Limited (TWG) -17%. Redwoods ...

Biopath Hikes On International Patents

7d ago, source:

Akamai Jumps on New Product <li /> Eagle Soars on Test Data Release <li /> TG Posts Gains on Results of MS Drug Test <li /> ...

Bio-Path Holdings, Inc.: Bio-Path Holdings Expands Global Patent Portfolio

7d ago, source:

Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to develop ...

Why Wang & Lee Group Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket

4d ago, source:

Wang & Lee Group posted a FY23 loss of 2 cents per share, versus a year-ago loss of 5 cents per share. The company's revenue came in at $6.83 million versus, $4.17 million in the year-ago period, ...

Acute Myeloid Leukemia Market Size is Expected to Grow by 2032 | DelveInsight

7d ago, source:

As per DelveInsight analysis, the Acute Myeloid Leukemia market is anticipated to witness growth at a considerable CAGR.

Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

4d ago, source:

Bio-Path Holdings, Inc., (Nasdaq: BPTH) (the “Company” or “Bio-Path”), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of ...